In this respect, due to the recognized pathogenic role of inflammation in MS, many clinical and preclinical studies have been performed to address the role of TNF and IL-1β in the modulation of synaptic plasticity [11]. The gene discussed is IL1B; the disease is myeloid sarcoma.